申请人:Yacovan Avihai
公开号:US20090068143A1
公开(公告)日:2009-03-12
The present invention relates to orally effective ligands of the peripheral cannabinoid receptor CB
2
, especially (+)-α-pinene derivatives, and to pharmaceutical compositions thereof, which are useful for prevention, alleviation or treatment of autoimmune neurodegenerative disorders, in particular multiple sclerosis and associated symptoms. Methods of the invention are useful when the active ingredient is administered alone or in combination with existing therapeutic modalities. The compositions are administered by oral route.